|
|
|
|
|
|
|
|
|
|
Note: As far as I can tell this test still needs approvals
OVANOME:
Ovanome is a genetic test for predicting an ovarian cancer patient’s response to first-regimen Taxol¹ and carboplatin (TC) chemotherapy. 30% of chemo-naive women do not respond to TC treatment and DNAPrint™ research shows that this problem is largely a function of genetic polymorphism.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.